Shannon Stapleton | Reuters
The drugstore chain reported fiscal fourth-quarter net income of $975 million, or 75 cents per share, down from $1.74 billion, or $1.33 per share, a year earlier. Revenue rose to $69.55 billion, from $66.89 billion a year prior. That's higher than analysts' expectations of $68.75 billion, according to Refinitiv.
이 소식을 빠르게 읽을 수 있도록 요약했습니다. 뉴스에 관심이 있으시면 여기에서 전문을 읽으실 수 있습니다. 더 많은 것을 읽으십시오:
CV, covid ? upload them on linkedin, it's a Microsoff company
$CLOV LFG.
$CLOV LfG